Picture of Sinopharm logo

1099 — Sinopharm News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Factbox: Countries weigh need for booster COVID-19 shots

(Re-arranges by regions and targeted groups, updates
throughout)
    By Reuters Staff
    Sept 24 (Reuters) - Many countries are preparing to make
COVID-19 vaccine booster shots available, but there is no
consensus among scientists that they are necessary and the World
Health Organization wants the most vulnerable people worldwide
to be fully vaccinated first.
 urn:newsml:reuters.com:*:nL8N2PP3XA urn:newsml:reuters.com:*:nL1N2PU0KM urn:newsml:reuters.com:*:nL1N2QB0V7
    The following outlines the options countries and regions are
considering on the issue:
    
    NORTH AMERICA
    The U.S. Centers for Disease Control and Prevention (CDC) on
Sept. 24 backed a booster shot of the Pfizer  PFE.N  and
BioNTech  22UAy.DE  vaccine for Americans aged 65 and older,
some adults with underlying medical conditions and some adults
in high-risk working and institutional settings.  urn:newsml:reuters.com:*:nL1N2QP2FD
    Canada's National Advisory Committee on Immunization is
recommending https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/summary-september-10-2021-additional-dose-covid-19-vaccine-immunocompromised-following-1-2-dose-series.html
 booster shots of an authorized mRNA vaccine to those who are
moderately or severely immunocompromised. 
        
    EUROPE
    European Union countries that decide to use COVID-19 vaccine
booster shots may face increased legal risks because the
additional dose has not yet been recommended by the EU drugs
regulator, the European Commission said on Aug. 26.  urn:newsml:reuters.com:*:nL8N2PX2D9
    Recent supply contracts with Pfizer/BioNTech and Moderna
 MRNA.O  have included the potential for the bloc to buy booster
shots. 
    These European countries are offering boosters to people
after they received a full dose of a vaccine: 
    Austria (wider rollout to start on Oct. 17); Czech Republic;
Hungary; Russia; Serbia     
    These countries are offering boosters to people with weak
immune systems, the elderly or vulnerable: 
    Belgium (mRNA); Britain (mRNA); Denmark; Finland (may expand
to other Finns later in the autumn); France; Germany (mRNA);
Ireland; Italy; Poland; Slovenia; Spain; Sweden (larger
population to get a jab in 2022) 
    
    ASIA, MIDDLE EAST
    These countries are offering boosters to people after they
received a full dose of a vaccine:
    ** Bahrain (Sputnik V, all over-18s at least six months
after second dose); Cambodia (AstraZeneca); Indonesia
(administered to health workers only, for wider population
planned in 2022); Israel (all over-12s); South Korea (initial
doses to high-risk groups or people with weakened immune
systems); Turkey; Thailand (AstraZeneca or mRNA-type booster
shots to people who were administered Sinovac brand); UAE
(mandatory for people inoculated with Sinopharm vaccine)
    These countries are offering boosters to people with weak
immune systems, the elderly or vulnerable:
    ** China; Singapore
    
    LATIN AMERICA
    These countries are offering boosters to people after they
received full dose of a vaccine:
    ** Uruguay (offers a Pfizer dose for those fully vaccinated
with Sinovac's vaccine)
    These countries are offering boosters only to the
immunosuppressed:
    ** Ecuador
    These are offering boosters to the elderly and vulnerable:
    ** Chile; Brazil; Dominican Republic
           
    COMPANIES
    The U.S. Food and Drug Administration authorized on Sept. 22
a booster dose of the Pfizer and BioNTech COVID-19 vaccine for
those 65 and older, all people at high risk of severe disease,
and others who are regularly exposed to the virus.  urn:newsml:reuters.com:*:nL4N2QO3UF
    The FDA authorized a third dose of COVID-19 vaccines by
Pfizer-BioNTech and Moderna Inc on Aug. 13 for people with
compromised immune systems.  urn:newsml:reuters.com:*:nL1N2PK23O 
    Pfizer and BioNtech also submitted data for COVID-19 vaccine
booster authorization to the European Medicines Agency (EMA).
 urn:newsml:reuters.com:*:nL1N2Q80W2
    Moderna said on Sept. 3 it had asked the EU drugs regulator
for conditional approval of a booster shot of its vaccine at a
50 microgram dose, or half the dosage of its two-shot vaccine. 
    The company also said it had completed data submission for
the use of a booster dose to the U.S. Food and Drug
Administration.  urn:newsml:reuters.com:*:nL4N2Q53B9
    On Aug. 5, Moderna said its COVID-19 shot was about 93%
effective four to six months after the second dose, showing
hardly any change from the 94% efficacy reported in its original
clinical trial.
    AstraZeneca said it was looking into how long the vaccine's
protection lasts and if a booster dose would be needed. 
    
    
    
    

    <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Explainer: Who is eligible for a third COVID-19 vaccine dose in
the U.S.?    https://www.reuters.com/business/healthcare-pharmaceuticals/who-is-eligible-third-covid-19-vaccine-dose-us-2021-08-15/
    ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
 (Compiled by Dagmarah Mackos, Veronica Snoj, Filipe Braganca;
Editing by Steve Orlofsky)
 ((anna.pruchnicka@tr.com; +48 587696514))

Recent news on Sinopharm

See all news